Armata Pharmaceuticals (ARMP) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.75% |
| Dec 31, 2025 | -7.08% |
| Sep 30, 2025 | -1.22% |
| Jun 30, 2025 | -7.17% |
| Mar 31, 2025 | -6.80% |
| Dec 31, 2024 | 7.40% |
| Sep 30, 2024 | 32.04% |
| Jun 30, 2024 | 30.91% |
| Mar 31, 2024 | 31.57% |
| Dec 31, 2023 | 35.53% |
| Sep 30, 2023 | 35.15% |
| Jun 30, 2023 | 26.96% |
| Mar 31, 2023 | 35.11% |
| Dec 31, 2022 | 55.57% |
| Sep 30, 2022 | 46.89% |
| Jun 30, 2022 | 42.48% |
| Mar 31, 2022 | 123.78% |
| Dec 31, 2021 | 68.65% |
| Sep 30, 2021 | 58.98% |
| Jun 30, 2021 | 60.31% |
| Mar 31, 2021 | 54.25% |
| Dec 31, 2020 | 52.52% |
| Sep 30, 2020 | 49.10% |
| Jun 30, 2020 | 48.49% |
| Mar 31, 2020 | 45.55% |
| Dec 31, 2019 | 11.92% |
| Sep 30, 2019 | 4.02% |
| Jun 30, 2019 | 6.04% |
| Mar 31, 2019 | -30.18% |
| Dec 31, 2018 | -22.70% |
| Sep 30, 2018 | -32.20% |
| Jun 30, 2018 | -31.44% |
| Mar 31, 2018 | -28.02% |
| Dec 31, 2017 | -26.99% |
| Sep 30, 2017 | -24.43% |
| Jun 30, 2017 | -24.23% |
| Mar 31, 2017 | -27.51% |
| Dec 31, 2016 | -23.91% |